134 related articles for article (PubMed ID: 1660761)
1. [A histopathological study of bone marrow following chemotherapy of acute myeloid leukemia].
Pu Q
Zhonghua Yi Xue Za Zhi; 1991 Aug; 71(8):431-3, 30. PubMed ID: 1660761
[TBL] [Abstract][Full Text] [Related]
2. Pattern of bone marrow regeneration following chemotherapy for acute myeloid leukemia.
Islam A
J Med; 1987; 18(2):108-22. PubMed ID: 3480927
[TBL] [Abstract][Full Text] [Related]
3. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
[TBL] [Abstract][Full Text] [Related]
4. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging of the bone marrow in patients with acute leukemia during and after chemotherapy. Changes in T1 relaxation.
Jensen KE; Grundtvig Sørensen P; Thomsen C; Christoffersen P; Henriksen O; Karle H
Acta Radiol; 1990 Jul; 31(4):361-9. PubMed ID: 2206692
[TBL] [Abstract][Full Text] [Related]
6. [Pathomorphosis of acute leukemia].
Popov VM
Sov Med; 1991; (9):15-8. PubMed ID: 1724709
[TBL] [Abstract][Full Text] [Related]
7. [A histopathological study of bone marrow in acute myeloid leukemia. Bone marrow biopsy changes before chemotherapy and comparison with bone marrow smears].
Pu Q; Tang CS; Zhou RH
Zhonghua Nei Ke Za Zhi; 1991 Sep; 30(9):566-8, 595. PubMed ID: 1806340
[TBL] [Abstract][Full Text] [Related]
8. [Modern strategies in therapy of acute myeloid leukemia (AML) in adulthood. I. Primary treatment of de novo AML].
Jehn U; Dengler R; Petrides PE
Internist (Berl); 1996 Jun; 37(6):661-8. PubMed ID: 8768003
[No Abstract] [Full Text] [Related]
9. A combination chemotherapy with low doses of cytarabine and etoposide for high risk myelodysplastic syndromes and their leukemic stage. A pilot study.
Kuriya S; Murai K; Miyairi Y; Utsugisawa T; Narigasawa Y; Ito T; Shimosegawa K; Ishida Y
Cancer; 1996 Aug; 78(3):422-6. PubMed ID: 8697386
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the myelogram carried out on the 6th day of remission- inducing treatment of acute nonlymphoblastic leukemia in adults as an indicator of therapeutic effectiveness].
Kniewska I; Hołowiecki J; Krykowski E; Rudzka E; Krzemień S; Krawczyk M; Duraj M; Brodowski L; Urbańska-Ryś H
Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):872-4. PubMed ID: 2487940
[TBL] [Abstract][Full Text] [Related]
11. Treatment of adult acute myelogenous leukemia: a pilot study at Chulalongkorn Hospital.
Intragumtornchai T; Sucharitchan P; Swasdikul D; Mahasandhana S; Watananukul P
J Med Assoc Thai; 1991 Jul; 74(7):265-71. PubMed ID: 1765741
[TBL] [Abstract][Full Text] [Related]
12. Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.
Lee SH; Abebe L; Paietta E; Einzig A; Wiernik PH
Am J Hematol; 2009 Jul; 84(7):455-7. PubMed ID: 19507211
[No Abstract] [Full Text] [Related]
13. Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by interleukin-2 administration.
Klingemann HG; Eaves CJ; Barnett MJ; Eaves AC; Hogge DE; Nantel SH; Reece E; Shepherd JD; Sutherland HJ; Phillips GL
Bone Marrow Transplant; 1994 Sep; 14(3):389-96. PubMed ID: 7994260
[TBL] [Abstract][Full Text] [Related]
14. [Differentiation induction of myeloid leukemia cells by glucocorticoid--the differentiation induction effect in vitro and in vivo].
Nakamaki T; Sakashita A; Sano M; Hino K; Suzuki K; Tomoyasu S; Tsuruoka N
Rinsho Ketsueki; 1989 Feb; 30(2):149-57. PubMed ID: 2746870
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow morphology during induction phase of therapy for acute myeloid leukemia (AML).
Dick FR; Burns CP; Weiner GJ; Heckman KD
Hematol Pathol; 1995; 9(2):95-106. PubMed ID: 7559259
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine-induced autologous graft-versus-host disease in patients with acute myeloid leukemia undergoing non-myeloablative chemotherapy without progenitor cell reinfusion.
Stein M; Feldman E; Seiter K; Chiao JW; Goff H; Baskind P; Beer M; Ahmed T
Bone Marrow Transplant; 1999 Nov; 24(10):1073-7. PubMed ID: 10578157
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
Dengler R; Plewan A; Münstermann U; Busch R; Eger G; Emmerich B
Clin Cancer Res; 1995 Feb; 1(2):199-205. PubMed ID: 9815974
[TBL] [Abstract][Full Text] [Related]
18. [Bone marrow transplantation versus maintenance chemotherapy for adult acute leukemia in first remission].
Suzuki R; Iida H; Taji H; Murata M; Sugihara T; Minami S; Kodera Y
Rinsho Ketsueki; 1996 Dec; 37(12):1362-70. PubMed ID: 8997123
[TBL] [Abstract][Full Text] [Related]
19. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report).
Mihál V; Hajdúch M; Dusek J; Jarosová M; Weigl E; Pikalová Z; Indrák K; Safárová M; Janostáková A
Neoplasma; 1997; 44(2):133-6. PubMed ID: 9201294
[TBL] [Abstract][Full Text] [Related]
20. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
Gustavsson A; Olofsson T
Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
